Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed tw...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Mol Hepatol
Egile Nagusiak: Song, Byung-Cheol, Cho, Yoo-Kyung, Jwa, Hyeyoung, Choi, Eun Kwang, Kim, Heung Up, Song, Hyun Joo, Na, Soo-Young, Boo, Sun-Jin, Jeong, Seung Uk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association for the Study of the Liver 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278066/
https://ncbi.nlm.nih.gov/pubmed/25548741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.4.355
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak